{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:25:37Z","timestamp":1776979537798,"version":"3.51.4"},"reference-count":37,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100006261","name":"Taif University, Saudi Arabia","doi-asserted-by":"publisher","award":["TURPS-2020\/51"],"award-info":[{"award-number":["TURPS-2020\/51"]}],"id":[{"id":"10.13039\/501100006261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Autoimmune hepatitis (AIH) is an inflammatory liver disease\nthat is characterized histologically by interface hepatitis, biochemically by elevated\ntransaminase levels, and serologically by the presence of autoantibodies. Toll-like\nreceptor (TLR)-4 is a TLR family member that, upon activation in hepatocytes, initiates a\ncascade of events. Interleukin-2 (IL-2) and tumour necrosis factor \u03b1 (TNF-\u03b1) are potent\ninflammatory cytokines secreted in AIH, playing an important role in the early\ndevelopment of inflammation and hepatocyte damage.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study examined the role of cyclosporine in AIH and illustrated its\nactions on altered hepatic function in the silica-induced AIH model.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>AIH was induced in Wistar rats using sodium silicate. The rats were divided\ninto four groups: the control group, silica-AIH group, cyclosporine-treated group, and\nprevention group. TLR-4 and IL-2 mRNA expressions in liver tissues were tested by RTPCR.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>AIH was associated with up-regulation of liver enzymes, IL-2 and TLR-4 gene\nexpression, while cyclosporine significantly down-regulated the expression of both. The\nrelative quantity of TLR-4 mRNA was 1\u00b10, 13.57\u00b11.91, 4\u00b10.38, and 2\u00b10 in control, AIH,\ncyclosporine, and prevention groups, respectively (p&lt;0.001). Also, the relative quantity\nof IL-2 mRNA was 1\u00b10, 14.79\u00b11.42, 7.07\u00b10.96, and 3.4\u00b10.55 in control, AIH,\ncyclosporine, and prevention groups, respectively (p&lt;0.001). Additionally,\nimmunohistochemical staining for TNF-\u03b1 in liver sections was increased in the silica-AIH\ngroup but was found to decrease in the cyclosporine-treated and prevention groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>This study advocates the therapeutic role of cyclosporine in treating\nimmune-mediated hepatic diseases. Cyclosporine improves histological alterations in the\nliver and inhibits the production of proinflammatory cytokines.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1566524022666220106154111","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T11:54:26Z","timestamp":1641556466000},"page":"87-95","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cyclosporine Ameliorates Silica-Induced Autoimmune Hepatitis in\nRat Model by Altering the Expression of Toll-Like Receptor-4,\nInterleukin-2, and Tumor Necrosis Factor-\u03b1"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9636-7485","authenticated-orcid":true,"given":"Sayed F.","family":"Abdelwahab","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics and Industrial Pharmacy, College of\nPharmacy, Taif University, Al-Haweiah, PO Box 11099, Taif 21944, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustafa M.","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Departments of Biochemistry, Minia University Minia 61511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M. M.","family":"Okasha","sequence":"additional","affiliation":[{"name":"Departments of Biochemistry, Minia University Minia 61511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany H. Abdel","family":"Naiem","sequence":"additional","affiliation":[{"name":"Departments of Biochemistry, Minia University Minia 61511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reham F.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Pathology, Faculty of Medicine, Minia\nUniversity Minia 61511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem A.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Departments of Biochemistry, Minia University Minia 61511, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2174\/1566524013363672","volume":"1","author":"Wen L.","year":"2001","unstructured":"Wen L.; Ma Y.; Bogdanos D.P.; Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity. Curr Mol Med 2001,1(3),379-389","journal-title":"Curr Mol Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"9437043","DOI":"10.1155\/2019\/9437043","volume":"2019","author":"Sucher E.","year":"2019","unstructured":"Sucher E.; Sucher R.; Gradistanac T.; Brandacher G.; Schneeberger S.; Berg T.; Autoimmune hepatitis\u2014immunologically triggered liver pathogenesis\u2014diagnostic and therapeutic strategies. J Immunol Res 2019,2019,9437043","journal-title":"J Immunol Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1053\/jhep.2002.30991","volume":"35","author":"Heneghan M.A.","year":"2002","unstructured":"Heneghan M.A.; McFarlane I.G.; Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 2002,35(1),7-13","journal-title":"Hepatology"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1517\/14728221003642027","volume":"14","author":"Pimentel-Nunes P.","year":"2010","unstructured":"Pimentel-Nunes P.; Soares J.B.; Roncon-Albuquerque R.; Dinis-Ribeiro M.; Leite-Moreira A.F.; Toll-like receptors as therapeutic targets in gastrointestinal diseases. Expert Opin Ther Targets 2010,14(4),347-368","journal-title":"Expert Opin Ther Targets"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-981-10-8684-7_3","volume":"1061","author":"Farrell G.C.","year":"2018","unstructured":"Farrell G.C.; Haczeyni F.; Chitturi S.; Pathogenesis of NASH: How metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease obesity, fatty liver and liver cancer. Adv Exp Med Biol 2018,1061,19-44","journal-title":"Adv Exp Med Biol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4238\/gmr.15027419","volume":"15","author":"Sun L.","year":"2016","unstructured":"Sun L.; Dai J.J.; Hu W.F.; Wang J.; Expression of toll-like receptors in hepatic cirrhosis and hepatocellular carcinoma. Genet Mol Res 2016,15(2),1-15","journal-title":"Genet Mol Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/hep.24625","volume":"55","author":"H&#xF6;sel M.","year":"2012","unstructured":"H&#xF6;sel M.; Broxtermann M.; Janicki H.; Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors. Hepatology 2012,55(1),287-297","journal-title":"Hepatology"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.imlet.2016.01.008","volume":"171","author":"Vaikunthanathan T.","year":"2016","unstructured":"Vaikunthanathan T.; Safinia N.; Lombardi G.; Lechler R.I.; Microbiota, immunity and the liver. Immunol Lett 2016,171,36-49","journal-title":"Immunol Lett"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e87977","DOI":"10.1371\/journal.pone.0087977","volume":"9","author":"Shen M.","year":"2014","unstructured":"Shen M.; Lu J.; Cheng P.; Ethyl pyruvate pretreatment attenuates concanavalin a-induced autoimmune hepatitis in mice. PLoS One 2014,9(2),e87977","journal-title":"PLoS One"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1101\/sqb.1999.64.573","volume":"64","author":"Ho I-C.","year":"1999","unstructured":"Ho I-C.; Kim J.; Szabo S.; Glimcher L.; Tissue-specific regulation of cytokine gene expression. Cold Spring Harb Symp Quant Biol 1999,64,573-584","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1046\/j.1365-2249.2003.02094.x","volume":"131","author":"Brown J.M.","year":"2003","unstructured":"Brown J.M.; Archer A.J.; Pfau J.C.; Holian A.; Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin Exp Immunol 2003,131(3),415-421","journal-title":"Clin Exp Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.4049\/jimmunol.175.3.1540","volume":"175","author":"Biburger M.","year":"2005","unstructured":"Biburger M.; Tiegs G.; &#x3B1;-galactosylceramide-induced liver injury in mice is mediated by TNF-&#x3B1; but independent of Kupffer cells. J Immunol 2005,175(3),1540-1550","journal-title":"J Immunol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/0961203308098192","volume":"18","author":"Al-Mogairen S.M.","year":"2009","unstructured":"Al-Mogairen S.M.; Al-Arfaj A.S.; Meo S.A.; Adam M.; Al-Hammad A.; Gad El Rab M.O.; Induction of autoimmunity in Brown Norway rats by oral and parenteral administration of sodium silicate. Lupus 2009,18(5),413-417","journal-title":"Lupus"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1023\/A:1010683817344","volume":"46","author":"Malekzadeh R.","year":"2001","unstructured":"Malekzadeh R.; Nasseri-Moghaddam S.; Kaviani M.J.; Taheri H.; Kamalian N.; Sotoudeh M.; Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis. Dig Dis Sci 2001,46(6),1321-1327","journal-title":"Dig Dis Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"e112384","DOI":"10.1371\/journal.pone.0112384","volume":"9","author":"Atta H.","year":"2014","unstructured":"Atta H.; El-Rehany M.; Hammam O.; Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression. PLoS One 2014,9(11),e112384","journal-title":"PLoS One"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"pdb. ip47","DOI":"10.1101\/pdb.ip47","volume":"2007","author":"Barbas CF","year":"2007","unstructured":"Barbas CF; Burton DR; Scott JK; Silverman GJ; Quantitation of DNA and RNA. CSH Protoc 2007,2007,pdb. ip47","journal-title":"CSH Protoc"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2144\/000112776","volume":"44","author":"VanGuilder H.D.","year":"2008","unstructured":"VanGuilder H.D.; Vrana K.E.; Freeman W.M.; Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 2008,44(5),619-626","journal-title":"Biotechniques"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2119\/molmed.2012.00306","volume":"19","author":"Kim S.","year":"2013","unstructured":"Kim S.; Kim S.Y.; Pribis J.P.; Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14. Mol Med 2013,19(1),88-98","journal-title":"Mol Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1136\/gut.34.12.1705","volume":"34","author":"Murch S.H.","year":"1993","unstructured":"Murch S.H.; Braegger C.P.; Walker-Smith J.A.; MacDonald T.T.; Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993,34(12),1705-1709","journal-title":"Gut"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/002215540405200104","volume":"52","author":"Kasprzak A.","year":"2004","unstructured":"Kasprzak A.; Zabel M.; Biczysko W.; Expression of cytokines (TNF-&#x3B1;, IL-1&#x3B1;, and IL-2) in chronic hepatitis C: Comparative hybridocytochemical and immunocytochemical study in children and adult patients. J Histochem Cytochem 2004,52(1),29-38","journal-title":"J Histochem Cytochem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/apt.12563","volume":"39","author":"Chen J.","year":"2014","unstructured":"Chen J.; Eslick G.; Weltman M.; Systematic review with meta\u2010analysis: clinical manifestations and management of autoimmune hepatitis in the elderly. Aliment Pharmacol Ther 2014,39(2),117-124","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1177\/0961203306069346","volume":"15","author":"Parks C.G.","year":"2006","unstructured":"Parks C.G.; Cooper G.S.; Occupational exposures and risk of systemic lupus erythematosus: A review of the evidence and exposure assessment methods in population- and clinic-based studies. Lupus 2006,15(11),728-736","journal-title":"Lupus"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.immuni.2011.03.019","volume":"34","author":"Kuroda E.","year":"2011","unstructured":"Kuroda E.; Ishii K.J.; Uematsu S.; Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity 2011,34(4),514-526","journal-title":"Immunity"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1254\/jjp.77.261","volume":"77","author":"Okamoto T.","year":"1998","unstructured":"Okamoto T.; Kobayashi T.; Effects of immunosuppressants on concanavalin A-induced interleukin-2 mRNA expression in mouse liver. Jpn J Pharmacol 1998,77(3),261-263","journal-title":"Jpn J Pharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/cns.12546","volume":"22","author":"Tajiri N.","year":"2016","unstructured":"Tajiri N.; Borlongan C.V.; Kaneko Y.; therapeutics. Cyclosporine a treatment abrogates ischemia\u2010induced neuronal cell death by preserving mitochondrial integrity through upregulation of the Parkinson's disease\u2010associated protein DJ\u20101. CNS Neurosci 2016,22(7),602-610","journal-title":"CNS Neurosci"},{"key":"ref=26","first-page":"3881","volume":"19","author":"Al-Mogairen S.M.","year":"2015","unstructured":"Al-Mogairen S.M.; Al Sheikh A.; Husain S.; Effect of exposure to silica in inducing autoimmune hepatitis: An experimental animal-controlled study. Eur Rev Med Pharmacol Sci 2015,19(20),3881-3885","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jphs.2015.12.006","volume":"130","author":"Zhai K-F.","year":"2016","unstructured":"Zhai K-F.; Duan H.; Cao W-G.; Protective effect of Rabdosia amethystoides (Benth) Hara extract on acute liver injury induced by concanavalin A in mice through inhibition of TLR4-NF-&#x3BA;B signaling pathway. J Pharmacol Sci 2016,130(2),94-100","journal-title":"J Pharmacol Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/357692a0","volume":"357","author":"O\u2019Keefe S.J.","year":"1992","unstructured":"O\u2019Keefe S.J.; Tamura J.; Kincaid R.L.; Tocci M.J.; O\u2019Neill E.A.; FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 1992,357(6380),692-694","journal-title":"Nature"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1006\/clin.1996.0140","volume":"80","author":"Ho S.","year":"1996","unstructured":"Ho S.; Clipstone N.; Timmermann L.; The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 1996,80(3 Pt 2),S40-S45","journal-title":"Clin Immunol Immunopathol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/lt.23712","volume":"19","author":"Howell J.","year":"2013","unstructured":"Howell J.; Sawhney R.; Testro A.; Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation. Liver Transpl 2013,19(10),1099-1107","journal-title":"Liver Transpl"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.4049\/jimmunol.179.7.4598","volume":"179","author":"Kang Y.J.","year":"2007","unstructured":"Kang Y.J.; Kusler B.; Otsuka M.; Calcineurin negatively regulates TLR-mediated activation pathways. J Immunol 2007,179(7),4598-4607","journal-title":"J Immunol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/1753425908100928","volume":"15","author":"Jennings C.","year":"2009","unstructured":"Jennings C.; Kusler B.; Jones P.P.; Calcineurin inactivation leads to decreased responsiveness to LPS in macrophages and dendritic cells and protects against LPS-induced toxicity in vivo. Innate Immun 2009,15(2),109-120","journal-title":"Innate Immun"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s12072-010-9196-0","volume":"4","author":"Zhang X.","year":"2010","unstructured":"Zhang X.; Wei H-X.; Rui S.; Wei H.; Tian Z.; Opposite effects of high and low doses of interleukin-2 on T cell-mediated hepatitis in mice (interleukin-2 on hepatitis). Hepatol Int 2010,4(3),641-648","journal-title":"Hepatol Int"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.bpj.2015.06.048","volume":"109","author":"Guven-Maiorov E.","year":"2015","unstructured":"Guven-Maiorov E.; Keskin O.; Gursoy A.; Nussinov R.; A structural view of negative regulation of the toll-like receptor-mediated inflammatory pathway. Biophys J 2015,109(6),1214-1226","journal-title":"Biophys J"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/modpathol.2011.197","volume":"25","author":"Vespasiani-Gentilucci U.","year":"2012","unstructured":"Vespasiani-Gentilucci U.; Carotti S.; Onetti-Muda A.; Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease. Mod Pathol 2012,25(4),576-589","journal-title":"Mod Pathol"},{"key":"ref=36","first-page":"145","volume":"9","author":"Robak T.","year":"1998","unstructured":"Robak T.; Gladalska A.; Stepie\u0144 H.; The tumour necrosis factor family of receptors\/ligands in the serum of patients with rheumatoid arthritis. Eur Cytokine Netw 1998,9(2),145-154","journal-title":"Eur Cytokine Netw"},{"key":"ref=37","first-page":"1129","volume":"8","author":"Chen Q.","year":"2013","unstructured":"Chen Q.; Xue Y.; Sun J.; Kupffer cell-mediated hepatic injury induced by silica nanoparticles in vitro and in vivo. Int J Nanomedicine 2013,8,1129-1140","journal-title":"Int J Nanomedicine"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566524022666220106154111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/200077\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566524022666220106154111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T12:23:23Z","timestamp":1676463803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/200077\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566524022666220106154111","relation":{},"ISSN":["1566-5240"],"issn-type":[{"value":"1566-5240","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-05-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}